Please ensure Javascript is enabled for purposes of website accessibility
Experimental COVID-19 Drug Cleared for Clinical Trials at Northern California Hospital
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
April 9, 2020

Share

“A promising investigational drug.”
Those words are being written quite a bit during these days as politicians, scientists, and the general public explore avenues for combating the COVID-19 pandemic.
Those same words were used in a press release from Saint Joseph Hospital in Humbolt County in announcing their participation in a new clinical trial of a drug developed by California-based Gilead Sciences.

Clinical Trials of Anti-Viral Drug Remdesivir

St Joseph Hospital in Eureka said in a news release that it is participating in two national clinical trials of the anti-viral drug remdesivir for the treatment of moderate and severe COVID-19. The experimental drug has shown promise in some recent emergency uses and patient trials.
“This is an important opportunity for future patients who present with COVID–19 at St. Joseph Hospital and meet certain criteria, to have access to remdesivir, a promising investigational drug,” said Dr. Roberta Luskin-Hawk, St. Joseph’s chief executive.
The hospital was chosen due to an established relationship with the principal investigator of the trial and was proactive in seeking accelerated approval for the trials in Humboldt.
Interest has been so great in remdesivir that the U.S. National Institutes of Health is expanding its study, which has nearly reached its initial goal of 440 patients. The NIH study is the most rigorous test. It compares remdesivir to placebo infusions, with neither patients nor doctors aware of who is getting which treatment until the end of the study.

How Remdesivir Works

Remdesivir is given through an IV. It’s designed to interfere with an enzyme that reproduces viral genetic material.
In animal tests against SARS and MERS, diseases caused by similar coronaviruses, the drug helped prevent infection and reduced the severity of symptoms when given early enough in the course of illness. It’s farther along in testing than many other potential therapies and current studies could lead to regulatory approval.
Online medical news site Stat News describes remdesivir this way: “The drug is designed to interfere with the process the virus, called SARS-CoV-2, uses to make copies of itself. The resulting copies of the virus lack their full RNA genome, so they can’t go on to replicate themselves or infect other cells.”
[covid-19-tracker]

‘Compassionate Use’ Allowed Under Emergency Regulations

In addition to patient trials, the U.S. Food and Drug Administration has authorized the use of remdesivir for treatment in a limited number of “compassionate use” cases.
“Gilead has given remdesivir to more than 1,700 patients on a case-by-case emergency basis, but more people ultimately will be helped if the company does the needed studies to prove safety and effectiveness,” Gilead chief executive Dan O’Day wrote in a open letter on the company’s website.
O’Day said the company has an inventory of 1.5 million doses, which could mean more than 140,000 treatment courses, depending on how long treatment needs to last. The company is providing the drug for free for now and has set a goal of making 500,000 treatment courses by October and more than a million by the end of the year.
Gilead supplied remdesivir for two studies in China expected to give results by the end of the month. It also launched two studies for hospitalized patients in the U.S., Asia, Europe and elsewhere.

Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)

A Remdesivir Recap With Mention of a ‘Red Flag’

“Stat News” recently reported on the trials and what might come next.
“Sometime this month, Chinese scientists will share results from two trials in that country, one looking at patients with severe Covid-19, and one with patients with mild and moderate infections,” the website reported.
“There is already one red flag. The investigators running the severe COVID-19 study in China have already taken an interim look at the data, but they did not stop the study early,” Stat News noted. “This suggests remdesivir isn’t working as well as hoped, and dampens optimism for an overall positive outcome.
“It’s also possible the trial will produce mixed results.”

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Fresno Unified Trustee Wittrup Says District Had Stronger Candidates Than Misty Her

DON'T MISS

Trump Poised to Offer Saudi Arabia Over $100 Billion Arms Package, Sources Say

DON'T MISS

Lights, Camera, Board Vote: Fresno Unified’s Carefully Choreographed Production

DON'T MISS

US Farm Agency Withdraws Proposal Aimed at Lowering Salmonella Risks in Poultry

DON'T MISS

On Major Economic Decisions, Trump Blinks, and Then Blinks Again

DON'T MISS

Candi Is the Dandy to Add a Little Sweetness to Your Life

DON'T MISS

How Trump Tariffs Could Upend California Farms, Wine Businesses, and Ports

DON'T MISS

Tulare Man Sentenced to State Prison for DUI Crash That Injured Two Women

DON'T MISS

Judge Partly Blocks Trump Order Seeking to Overhaul US Elections

DON'T MISS

Two From Search Group That Uncovered Mexico’s ‘Ranch of Horror’ Killed

UP NEXT

Survey: Californians Blame Utility Company Spending, Profits for High Electricity Rates

UP NEXT

Chicago Bears Great Steve McMichael Dies at 67 After Battle With ALS

UP NEXT

Long Wait Is Over for Cam Ward, Travis Hunter and Other Draft Prospects Joining the NFL

UP NEXT

Golden State’s Jimmy Butler Injured in Game 2 Loss, His Status for Game 3 Unknown

UP NEXT

Jalen Green Makes Eight 3s to Help Rockets Even Series With Warriors

UP NEXT

Newsom Seeks Help for Struggling Oil Refiners

UP NEXT

US Justice Department Directs Investigations Over Gender-Affirming Care

UP NEXT

Kennedy Declares ‘Sugar Is Poison’ While Announcing Ban on Food Dyes

UP NEXT

US Justice Department Cancels Hundreds of Grants for Police, Crime Victims

UP NEXT

How Do High Schoolers Really Fare After Graduation? A New California Tool Lets You Know

US Farm Agency Withdraws Proposal Aimed at Lowering Salmonella Risks in Poultry

2 hours ago

On Major Economic Decisions, Trump Blinks, and Then Blinks Again

2 hours ago

Candi Is the Dandy to Add a Little Sweetness to Your Life

2 hours ago

How Trump Tariffs Could Upend California Farms, Wine Businesses, and Ports

3 hours ago

Tulare Man Sentenced to State Prison for DUI Crash That Injured Two Women

4 hours ago

Judge Partly Blocks Trump Order Seeking to Overhaul US Elections

4 hours ago

Two From Search Group That Uncovered Mexico’s ‘Ranch of Horror’ Killed

4 hours ago

US Warns States They Could Lose Transportation Funding Over Immigration, DEI Policies

5 hours ago

Don’t Miss Out! Tower District’s Porchfest Festival Is Saturday

5 hours ago

Shooter in 2022 Chicago-Area Parade Massacre Sentenced to Life in Prison

5 hours ago

Fresno Unified Trustee Wittrup Says District Had Stronger Candidates Than Misty Her

Fresno Unified Trustee Susan Wittrup says the district had an opportunity to select an experienced superintendent with a track record of suc...

6 minutes ago

6 minutes ago

Fresno Unified Trustee Wittrup Says District Had Stronger Candidates Than Misty Her

President Donald Trump delivers remarks during an 'Unleashing American Energy' event at the Department of Energy in Washington, U.S., June 29, 2017. (REUTERS File)
52 minutes ago

Trump Poised to Offer Saudi Arabia Over $100 Billion Arms Package, Sources Say

2 hours ago

Lights, Camera, Board Vote: Fresno Unified’s Carefully Choreographed Production

Chickens sit at a poultry farm. March 12, 2025. (REUTERS/Diego Vara/File Photo)
2 hours ago

US Farm Agency Withdraws Proposal Aimed at Lowering Salmonella Risks in Poultry

2 hours ago

On Major Economic Decisions, Trump Blinks, and Then Blinks Again

Candi, GV Wire's Adoptable Cat of the Week
2 hours ago

Candi Is the Dandy to Add a Little Sweetness to Your Life

3 hours ago

How Trump Tariffs Could Upend California Farms, Wine Businesses, and Ports

Maxwell Barrios, 28, of Tulare, was sentenced to over four years in state prison on Wednesday, April 23, 2025, for a 2023 DUI crash that seriously injured two women, including one who required a partial arm amputation. (Tulare County DA)
4 hours ago

Tulare Man Sentenced to State Prison for DUI Crash That Injured Two Women

Help continue the work that gets you the news that matters most.

Search

Send this to a friend